AU2013230896B2 - Methods for enhancing, improving, or increasing fertility or reproductive function - Google Patents

Methods for enhancing, improving, or increasing fertility or reproductive function Download PDF

Info

Publication number
AU2013230896B2
AU2013230896B2 AU2013230896A AU2013230896A AU2013230896B2 AU 2013230896 B2 AU2013230896 B2 AU 2013230896B2 AU 2013230896 A AU2013230896 A AU 2013230896A AU 2013230896 A AU2013230896 A AU 2013230896A AU 2013230896 B2 AU2013230896 B2 AU 2013230896B2
Authority
AU
Australia
Prior art keywords
omega
fatty acids
acid
supplement
dha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013230896A
Other languages
English (en)
Other versions
AU2013230896A1 (en
Inventor
Deepika NEHRA
Mark Puder
Bo R. Rueda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Boston Childrens Hospital
Original Assignee
General Hospital Corp
Boston Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp, Boston Childrens Hospital filed Critical General Hospital Corp
Publication of AU2013230896A1 publication Critical patent/AU2013230896A1/en
Application granted granted Critical
Publication of AU2013230896B2 publication Critical patent/AU2013230896B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AU2013230896A 2012-03-07 2013-03-07 Methods for enhancing, improving, or increasing fertility or reproductive function Active AU2013230896B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261607884P 2012-03-07 2012-03-07
US61/607,884 2012-03-07
US201261695510P 2012-08-31 2012-08-31
US61/695,510 2012-08-31
PCT/US2013/029553 WO2013134482A1 (en) 2012-03-07 2013-03-07 Methods for enhancing, improving, or increasing fertility or reproductive function

Publications (2)

Publication Number Publication Date
AU2013230896A1 AU2013230896A1 (en) 2014-09-25
AU2013230896B2 true AU2013230896B2 (en) 2016-05-19

Family

ID=47892067

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013230896A Active AU2013230896B2 (en) 2012-03-07 2013-03-07 Methods for enhancing, improving, or increasing fertility or reproductive function

Country Status (6)

Country Link
US (1) US9295662B2 (enExample)
EP (1) EP2822403B1 (enExample)
JP (1) JP6424091B2 (enExample)
AU (1) AU2013230896B2 (enExample)
CA (1) CA2866606C (enExample)
WO (1) WO2013134482A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6284768B2 (ja) * 2014-01-16 2018-02-28 株式会社紀州ほそ川 不妊治療剤
US10004711B2 (en) * 2014-05-08 2018-06-26 Dsm Ip Assets B.V. Methods and compositions comprising 10-hydroxy-2-decenoic acid
BR112017002553A2 (pt) * 2014-09-30 2017-12-05 Nestec Sa composição nutricional a ser usada para tratar ou prevenir condições relacionadas à gravidez
JP6788381B2 (ja) * 2016-05-30 2020-11-25 岩手県 酸化ストレス抑制剤
GR1009657B (el) * 2016-11-07 2019-11-28 Βαρβαρα Γεωργιου Γελαδακη Συνθεσεις για χορηγηση απο το στομα με ανοσοτροποποιητικη δραση στα φυσικα φονικα κυτταρα
WO2025231097A1 (en) * 2024-05-02 2025-11-06 Cold Spring Harbor Laboratory Use of arachidonic acid for promoting endometrial epithelium regeneration and stem cell plasticity

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020150607A1 (en) * 2000-12-05 2002-10-17 Pbm Pharmaceuticals, Inc. Food bars containing nutritional supplements
WO2003017945A2 (en) * 2001-08-24 2003-03-06 Martek Biosciences Boulder Corporation Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
US20080226746A1 (en) * 2005-08-04 2008-09-18 Vertical Pharmaceuticals, Inc. Nutritional supplement for women

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY118354A (en) 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
IL125097A (en) 1998-06-25 2003-01-12 Israel State Dietary manipulation to increase fertility
US6576667B2 (en) * 2001-11-14 2003-06-10 Norel Acquisition Corp. Method for manufacturing fatty acid calcium salts from high glyceride content oils
US20040254357A1 (en) 2002-12-19 2004-12-16 Zaloga Gary P. Fatty acid phenolic conjugates
US8652508B2 (en) 2007-05-25 2014-02-18 Children's Medical Center Corporation Dietary formulations and methods for treatment of inflammation and other disorders

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020150607A1 (en) * 2000-12-05 2002-10-17 Pbm Pharmaceuticals, Inc. Food bars containing nutritional supplements
WO2003017945A2 (en) * 2001-08-24 2003-03-06 Martek Biosciences Boulder Corporation Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
US20080226746A1 (en) * 2005-08-04 2008-09-18 Vertical Pharmaceuticals, Inc. Nutritional supplement for women

Also Published As

Publication number Publication date
US9295662B2 (en) 2016-03-29
JP6424091B2 (ja) 2018-11-14
WO2013134482A1 (en) 2013-09-12
EP2822403A1 (en) 2015-01-14
AU2013230896A1 (en) 2014-09-25
JP2015510760A (ja) 2015-04-13
CA2866606C (en) 2022-03-15
CA2866606A1 (en) 2013-09-12
EP2822403B1 (en) 2022-05-04
US20150025048A1 (en) 2015-01-22

Similar Documents

Publication Publication Date Title
Nehra et al. Prolonging the female reproductive lifespan and improving egg quality with dietary omega‐3 fatty acids
US7084175B2 (en) Animal food and method
AU2013230896B2 (en) Methods for enhancing, improving, or increasing fertility or reproductive function
Moallem et al. Dietary α-linolenic acid from flaxseed oil or eicosapentaenoic and docosahexaenoic acids from fish oil differentially alter fatty acid composition and characteristics of fresh and frozen-thawed bull semen
Jafaroghli et al. Effects of dietary n− 3 fatty acids and vitamin C on semen characteristics, lipid composition of sperm and blood metabolites in fat-tailed Moghani rams
AU2001265273A1 (en) Animal food and method
KR20000075539A (ko) 괴사성 소장 결장염의 발병률을 감소시키는 방법 및 이를 위한조성물
CN101437508A (zh) 用于改善心血管健康的十八碳四烯酸
CN112384203A (zh) 用于胃肠外施用的脂质乳剂
WO1999066877A2 (en) Dietary manipulation to increase fertility
Hess et al. Enrichment of intestinal mucosal phospholipids with arachidonic and eicosapentaenoic acids fed to suckling piglets is dose and time dependent
Soydan et al. Relationship between dietary fatty acids and reproductive functions in dairy cattle
WO2004056370A1 (en) Use of a fatty acid composition for treatment of male infertility
Xiang et al. Relation between polyunsaturated fatty acids and growth
WO2008064445A2 (en) Oily parenteral formulation for the enhancement of the reproductive performance of production animals
Abdel-Khalek et al. Effect of Different Dietary Sources of Oils on Growth Performance and Profile of Lipid, Testosterone and Fatty Acids in Rabbit Bucks.
CA3024191C (en) Composition for use in the prophylaxis of allergic disease
Shipman Impact of Dietary Essential Fatty Acids on the Subsequent Reproduction of Sows
MX2007001778A (es) Suplemento de alimentacion para ganado y metodo para implementarlo.
Mundra Maternal diet fat alters milk fatty acids, suckling pups’ intestinal phospholipid fatty acids and intestinal responsiveness to experimental colitis
Cerri Endocrine and nutritional factors affecting fertilization and early embryo development in dairy cows
Vilchez Effect of supplemental dietary fat on the reproductive performance of hens of turkey and Japanese quail

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)